The principle of photodynamic inactivation was first described by Raab (1900) in experiments with paramecia. In low concentrations of methylene blue, paramecia died rapidly on exposure to daylight while remaining alive if kept in the dark. Perdrau and Todd (1933) and Shortt and Brooks (1934) showed that viruses were photosensitized by methylene blue. Hiatt, Kaufmann, Helprin, and Baron (1960) extended the work of Yamamoto (1958) , on the photodynamic inactivation of bacteriophage, to certain animal viruses including herpes simplex virus (HSV). Wallis and Melnick (1964) described how certain heterotricyclic dyes could be bound irreversibly to herpes virus in vitro, subsequent brief exposure to fluorescent light causing inactivation of the virus. The most effective dyes were found to be neutral red, proflavine, and toluidine blue. The following year the same authors (Wallis and Melnick, 1966) reviewed this photodynamic inactivation of viruses and suggested that treatment of herpetic lesions with heterotricyclic dyes and light might be clinically beneficial. Moore, Wallis, Melnick, and Kuns (1972) had good results from treatment using photodynamic inactivation in experimentally induced herpes keratitis in rabbits. Felber, Smith, Knox, Wallis and Melnick (1971) reported that 87 per cent. of sixty patients with recurrent labial or genital HSV said that the results of this method of treatment were better than those of anything they had tried before. In a further study the same authors (Felber, Smith, Knox, Wallis, and Melnick, 1973) Hood, quoted by Walls and others (1972) , had comparable successes to those of Felber and others (1973) in herpes genitalis of the penis and vulva. Lefebvre and McNelis (1973) had similar results in eleven cases and Schneider and Geary (1971) reported comparable success in herpes simplex vulvitis. Friedrich (1973) reported marked relief of symptoms in twenty-four of thirty patients with herpes vulvitis within 36 hours and healing usually within 7 days. It was suggested in the British Medical Journal (1974) that an added advantage of photodynamic inactivation might be that the dye minimized secondary bacterial infection.
Of other treatments for herpetic infection, systemic cytarabine has been used in herpetic vulvitis with good results by Juel-Jensen (1973) . The most widely used remedy is probably 5-iodo-2' deoxyuridine (IDU). Hutfield (1964) reported favourably on the use of this agent. Schofield (1964) reported that the healing time in 22 patients with previous herpetic infection was halved. Prusoff (1967) recommended IDU for the treatment of herpetic infection. However Ng, Reagan, and Yen (1970) reported that the duration of the disease and the incidence of recurrent lesions were unaffected by local IDU 3-hourly in twenty-two patients with herpes simplex vulvitis. Wallis and others (1972) also reported unsatisfactory results in herpes genitalis using IDU ointment, and Kaufman, Mantola, and Dohlman (1962) reported that the good results of aqueous IDU in herpetic keratitis had not been duplicated in genital herpetic infection. Juel-Jensen (1973) (Stuart, 1946) Results 58 patients were studied (Table I ). Of these 39 had positive cultures for HSV. The remainder were excluded from the trial. Three further patients, one from each study group, did not return after their first attendance and were also excluded, leaving 36 patients for assessment.
The healing time of the lesions is shown in Table II . There was no increase in healing rate between 7 and 14 days, although at 21 days almost twice as many had healed in all three groups. group.bmj.com on June 20, 2017 -Published by http://sti.bmj.com/ Downloaded from virus as determined by HSV culture was also quicker in the recurrent cases (Table VI) .
Symptoms (pain, discomfort, and irritation) were each scored at each visit as 1 (if present) and 0 (if absent). The duration of symptoms after treatment in the three groups is shown in Table VII . No symptoms were present in any group after 7 days.
There was some correlation between the rate of healing of the lesions and the initial size of the lesions (Table VIII) . The larger the initial lesion, the longer it took to heal.
Discussion
By the use of an objective assessment by measurement of the lesions at each attendance, it has been demonstrated that with proflavine photoinactivation the area of the lesions was larger at all stages of treatment when compared with the initial area, than in the groups treated with IDU or normal saline (Table IV) . This difference is significant at the level of P < 0-01 in both groups. In four cases the affected areas became larger (two of them markedly so) after treatment for one day with proflavine, while lesions in only one case in each of the other two groups increased in size after the first day. The healing time was also longer in the proflavine group compared with the other two groups (Table II) and the time of disappearance of the virus as measured by culture for HSV was longer in the proflavine group compared with the other two groups (Table III) . Rawls, Gardner, Flanders, Lowry, Kaufman, and Melnick (1971) The finding of Kaufman, Gardner, Brown, Wallis, Rawls, and Melnick (1973) that there was no dramatic relief of pain with photoinactivation has been substantiated (Table VII) . While Felber and others (1973) described photodynamic inactivation as safe, two acute allergic reactions were described by Lefebvre and McNellis (1973) in areas surrounding those exposed to neutral red, both occurring in patients with a past history of allergy.
We may conclude that proflavine photoinactivation is of no greater value in the treatment of genital infection by HSV in the male than 0 5 per cent. IDU or normal saline. There was no significant difference in the results of treatment by the latter two methods. Summary 36 male patients with genital infection by HSV confirmed by culture were each allocated to one of three treatment groups:
(1) Proflavine photoinactivation, (2) 0 5 per cent. idoxuridine ointment (IDU), (3) Normal saline.
They were assessed objectively at each attendance by measurement of the lesions with an operating microscope fitted with a measuring grid in one eyepiece. Material for culture for HSV was taken at each visit; the presence of symptoms (pain, discomfort, and irritation) was noted.
The areas of lesions in the proflavine photoinactivation group remained larger significantly longer than in the other groups, the healing time was slower, and HSV could be isolated for longer. It is concluded that proflavine photoinactivation is of no greater value than 0-5 per cent. IDU or normal saline in the treatment of genital infection by HSV in the male. 
